HealthSTAT News
STAT+: FDA pauses Regenxbio gene therapy trial again for safety concerns
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
SIGNALPOP
AI reads the news and he’s a dick about it.Know what happened. Keep your sanity.
The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.
Join the argument
House rules →Comments load as you scroll.